- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate
Vadadustat is an investigational drug belonging to a class known as hypoxia-inducible prolyl hydroxylase inhibitors (HIF-PHIs) for the treatment of anemia in chronic kidney disease.
John Butler, CEO of Akebia Therapeutics, discusses the company's investigational drug candidate vadadustat, which belongs to a new class of drugs called hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI). The class works by restoring production of the hormone erythropoietin and improving iron regulation in patients with chronic kidney disease who are anemic.
Transcript:
Can you discuss vadadustat as an HIF-PH inhibitor and how this class of drugs works?
So vadadustat is a HIF-PHI, which is a hypoxia-inducible prolyl hydroxylase inhibitor and basically, its mechanism of action is the same as increasing altitude. When we go up in altitude, our body stabilizes hypoxia inducible factor, our body recognizes that the oxygen level is low, and it stabilizes HIF. And it does this by inhibiting the enzymes that normally inhibit HIF. So vadadustat basically works by inhibiting the inhibitor, inhibiting the pro hydroxylase which allows HIF to stabilize, which allows the body to make red blood cells. So it's a very physiologic process by which vadadustat works.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
